Peritoneal Carcinomatosis — Trials

Peritoneal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 42
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: University of California, Irvine
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05159050	Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis	terminated	Phase 1	4	Carlos ChanOTHER	1	Feb 25, 2026	clinicaltrials
NCT04665921	A Study of SGN-STNV in Advanced Solid Tumors	terminated	Phase 1	111	Seagen Inc.INDUSTRY	6	Feb 7, 2025	clinicaltrials
NCT04583488